Skip to main content

Table 4 Mean dose-adjusted plasma concentrations and metabolic ratios in the different CYP2D6 phenotypes (n = 68)

From: Risperidone plasma level, and its correlation with CYP2D6 gene polymorphism, clinical response and side effects in chronic schizophrenia patients

 

IMs (n = 38)

NMs (n = 30)

Statistics

p

RIP (ng/ml)

14.23 (10.79)

4.75 (3.93)

Z=-4.190

< 0.001

9-OH-RIP (ng/ml)

37.43 (18.82)

35.74 (14.55)

t = 407

0.685

Active moiety (ng/ml)

51.67 (24.62)

40.49 (13.76)

Z=-1.686

0.092

RIP/9-OH-RIP

0.44 (0.44)

0.20 (0.25)

t = 2.703

0.009

RIP/D (ng/ml/mg)

3.64 (3.45)

1.08 (1.09)

Z=-4.238

< 0.001

9-OH-RIP/D (ng/ml/mg)

8.89 (5.01)

7.20 (2.68)

Z=-1.204

0.092

C/D (ng/ml/mg)

12.53 (7.07)

8.28 (2.93)

Z=-2.940

0.003

  1. Values expressed as mean (standard deviation). RIP Risperidone, 9-OH-RIP 9-hydroxy-risperidone, Active moiety, the sum of risperidone plus 9-OH-RIP, D daily dose of oral risperidone, C/D, the total risperidone concentration-to-dose (C/D) ratio
  2. Statistically significant p values are in bold